AKTX Stock Summary and Trading Ideas (Akari Therapeutics PLC - American Depositary Shares | NASDAQ:AKTX)

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Akari Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AKTX.

As of April 23, 2024, AKTX stock price climbed to $1.21 with 4,786 million shares trading.

AKTX has a market cap of $6.12 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AKTX stock traded as high as $54.80 and as low as $1.08.

AKTX has underperformed the market in the last year with a price return of -72.7% while the SPY ETF gained +24.3%. AKTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -51.6% and -13.6%, respectively, while the SPY returned +4.9% and -2.5%, respectively.

AKTX support price is $1.07 and resistance is $1.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKTX stock will trade within this expected range on the day.